<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Assessing CAR-T Cell Therapy for Pancreatic Cancer with PDX Models

Despite an improvement in our knowledge of pancreatic cancer biology, standard of care treatment is still the chemotherapy gemcitabine, approved 20 years ago. Novel treatment strategies are urgently needed, including novel immunotherapies.